Thermo Fisher Scientific Inc. (TMO)

417.00
3.80 0.89
NYSE
Prev Close 420.76
Open 419.49
Day Low/High 416.01 / 421.11
52 Wk Low/High 250.21 / 441.96
Volume 168.62K
Exchange NYSE
Shares Outstanding 395.59B
Market Cap 170.20B
P/E Ratio 46.56
Div & Yield N.A. (N.A)
Jim Cramer: Stay Long Thermo Fisher, Sell FEI

Jim Cramer: Stay Long Thermo Fisher, Sell FEI

Thermo Fisher plans to buy microscope maker FEI for about $4.2 billion and Jim Cramer says FEI shareholders should take the money and run.

First-Quarter GDP Revised Upward; Futures Indicate Higher Opening

Also, Thermo Fisher annouces an acquisition as takeover talks boost Valeant shares. 

Valeant's Audit Committee Deserves More Scrutiny: Experts

As Valeant launches allegations of improper financial reporting at its former CFO, experts say it ought to take a close look at the composition of its audit committee.

Thermo Fisher Should Continue Upward Trend Despite Failed Affymetrix Bid

Thermo Fisher Should Continue Upward Trend Despite Failed Affymetrix Bid

We would anticipate a breakout to upside; a decline below $130 would turn us neutral on TMO. 

How 2 Companies Screwed Up on Guidance

How 2 Companies Screwed Up on Guidance

Stanley Black & Decker and Thermo Fisher provide an unfortunate lesson.

4 Reasons for Greater Caution

4 Reasons for Greater Caution

While we don't want to alarm readers, we are increasingly concerned around the market's movement heading into year-end.

Making Sense of a Rugged Day

Making Sense of a Rugged Day

Let's break it down into several components.

Technical Diagnosis of Thermo Fisher: Good Gets Great After $130

Technical Diagnosis of Thermo Fisher: Good Gets Great After $130

Momentum readings are improving.

Thermo Fisher Scientific, a Port in the Storm

Thermo Fisher Scientific, a Port in the Storm

The management recently gave a very upbeat presentation.

It's Show Me Time With Earnings, Apple Reports Tuesday

It's Show Me Time With Earnings, Apple Reports Tuesday

Traders can finally shift focus from macro headlines in Greece and China as earnings are in full swing with hundreds of companies expected to report quarterly results.

Earnings Season Heats Up Next Week; Apple Reports Tuesday

Earnings Season Heats Up Next Week; Apple Reports Tuesday

Traders can finally shift focus from macro headlines in Greece and China as earnings go into full swing next week with hundreds of companies expected to report quarterly results.

Thermo Fisher Equipped With Bullish Wedge

Thermo Fisher Equipped With Bullish Wedge

TMO is a buy after a strong close above the wedge downtrend line.

Pall Deal Wouldn't Make Sense for Thermo

There's no reason for Thermo to start a bidding war.

Taking Matters Into Their Own Hands

Companies get proactive to boost their stocks.

Market Wrap: Takeover Tuesday

Merger mania was the theme today.

Why Good Is Actually Good

Rates have lots of room to rise before this economy gets derailed.

Stocks Pare Losses as Pall Corporation Jumps on Potential Auction

Stocks Pare Losses as Pall Corporation Jumps on Potential Auction

Pall Corporation (PLL) rocketed higher on reports the manufacturer of filtration systems is in the late stages of an auction.

Don't Get Sucked Into AOL-Verizon Frenzy

Don't Get Sucked Into AOL-Verizon Frenzy

Balance the futures vs. the actuals.

Charge Into MasterCard, Thermo Fisher Says Morgan Stanley Manager

Charge Into MasterCard, Thermo Fisher Says Morgan Stanley Manager

MasterCard (MA) shares may be fairly priced, but the company continues to capitalize on the secular trend toward a cashless society.

Jim Cramer, Analysts on How to Invest in Health Care at Any Age

Jim Cramer, Analysts on How to Invest in Health Care at Any Age

Perspectives from Wall Street looks at how investors at any age can find opportunities in the health care sector.

Jim Cramer Explains Why Panera and Thermo Fisher Are Both Buys

Jim Cramer Explains Why Panera and Thermo Fisher Are Both Buys

Panera and Thermo Fisher may be in completely different industries, but they both are undervalued at these levels.

Day Ahead: Earnings, Housing Data Dominate

Day Ahead: Earnings, Housing Data Dominate

And have we mentioned Greece?

The 7 Pillars of Healthcare Strength

The 7 Pillars of Healthcare Strength

Here are healthcare stocks of all shares and sizes with strong charts.

Thermo Fisher rated new Buy at Keybanc

Buy Into Those Fear-Driven Selloffs

Buy Into Those Fear-Driven Selloffs

There is a disconnect between stock prices and intrinsic value.

Fitz Bits: Buying Opportunity This Week

Fitz Bits: Buying Opportunity This Week

After moves like last week, buyers tend to nibble.

Fitz Bits: Just Stick With What's Working

Fitz Bits: Just Stick With What's Working

And don't try to catch every move.

The Trader Daily

The Trader Daily

Two stock charts have caught my eye.

My 'Delivering Alpha' Takeaways

My 'Delivering Alpha' Takeaways

Three brilliant managers laid out their best ideas.

Akers CEO: We Are Growing Globally and Now Is the Time for Investors to Take Notice

Akers CEO: We Are Growing Globally and Now Is the Time for Investors to Take Notice

Akers Biosciences makes rapid, point-of-care screening and testing products designed to rapidly bring health care information direct to the consumer or provider.